The medical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike shots, this approach offers a more convenient way to deliver GLP-1 therapies. These devices steadily release the medication through the epidermis offering a stable amount of the beneficial agent, which can enhance gluc… Read More